Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lamb Weston Reports First Quarter Fiscal 2026 Results; Reaffirms Fiscal Year 2026 Outlook
-
UiPath Collaborates with OpenAI on Enterprise Agentic Automation
-
Thumzup Announces $2.5 Million Capital Infusion into DogeHash Technologies to Expand its Dogecoin Mining Capacity
-
AmpliTech Group Joins ORAN Alliance and Telecom Infra Project
-
Black Cultural Influence is the Blueprint and Brand Trust is the Key -- Urban One Conducts Landmark 'Cultural ROI' Study, Urges Brands: Get Real or Get Left Behind
-
BTIG Deepens Industrials Investment Banking Expertise: Appoints Michael Moen to Lead Minerals, Metals and Mining Coverage
-
Checkmarx One for Government Application Security Platform Achieves FedRAMP Ready Status at the High Impact Level
-
ZOOZ Completes Initial Purchase of ₿525 Valued at $60 Million, Becomes the First Dual-listed (Nasdaq and TASE) Company to Launch a Bitcoin Treasury Reserve Strategy
-
Amorphical Announces Positive Interim Results from Ongoing Clinical Trial in Crohn's Disease
-
UiPath Accelerates AI Transformation with Expanded Capabilities for its UiPath Platform for Agentic Automation and Orchestration
-
Beyond 3+3: Rethinking Early-Phase Oncology Study Design, Upcoming Webinar Hosted by Xtalks
-
New Drug Testing Analyzer from Siemens Healthineers Raises the Bar for Court, Military, and Forensics Testing, Offering Clinical-Quality Results
-
Everbridge and ASIS International Reveal Executive Protection Trends Amid Heightened Threat Landscape
-
Global Payments Appoints Nathan Rozof as Head of Investor Relations
-
Crossroads Summit 2025: Intimate Conversations on AI, Markets, and Innovation at The Biltmore
-
Moving the Needle in Vaccine Trials: Optimizing Digital Endpoint and Operational Strategies to Enable Study Success, Upcoming Webinar Hosted by Xtalks
-
UiPath Delivers Trusted Agentic Automation for Sensitive Workflows with NVIDIA
-
NanoCell Therapeutics Announces Three Strategic Appointments to its Scientific Advisory Board
-
Cannabix Technologies Announces First Sale of BreathLogix Alcohol Screening Device to Maritime Market
-
Advisor.com, WSJ Buy Side Enter Strategic Business Partnership to Expand Access to Financial Advice
-
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe
-
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access
-
ReSource Pro Launches The Insurance Lead: A New Voice for Insurance
-
REPAY Enhances Fuse’s AI-Powered Lending Software with New Integration
-
Service Line Warranties of America Repair Program Helps Homeowners Stay Protected
-
UiPath Simplifies Agentic Automation with Voice Agents with Google’s Gemini Models
-
FirstEnergy’s Pennsylvania Default Service Program DSP-VI Auction: Part 1 Applications Due from Prospective Bidders by Thursday, October 9, 2025
-
Dynatrace Achieves the AWS Generative AI Competency
-
World’s Best Companies 2025: MAPEI Is Among the Best Companies in the World
-
Webcast Alert: Olympic Steel to Announce Third-Quarter 2025 Financial Results After Market Closes on October 30, 2025
-
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
-
Draganfly Selected by U.S. Army to Supply Flex FPV Drone Systems
-
DSG Global Announces Formal Launch of Fundraising & Advancement as Specialized Practice
-
Abby Connect Scales Personalized Service and Launches AI Receptionist With Deepgram’s Real-Time Speech-to-Text
-
UiPath Announces Partnership with Snowflake to Unite Agentic Automation and Snowflake Cortex AI
-
California Pizza Kitchen Celebrates National Pizza Month with $5 Kick Back, $5 Jack-O-Lantern Pizzas and Two New Craveable Pizza Creations
-
Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
-
Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial
-
Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia
-
FangDD is Powered by AI System With US$34.32 Million Assets Acquisition
-
24/7 Market News: Analyst Upgrades amongst Flurry of Moves Venu Holdings Coverage
-
NewtekOne, Inc. Declares a Quarterly Dividend of $0.19 per Share
-
Amaze Hosts Breakaway Music Festival’s Creator Lab Official Merchandise Store
-
ZenaTech Developing Proprietary Quantum Computing Hardware Platform for Defense, Infrastructure and Drone Fleet Projects
-
IBN Announces Beeline Holdings Inc. CEO Nick Liuzza Featured in Exclusive Benzinga Podcast Interview Highlighting Beeline’s AI-powered, Digital Mortgage Platform
-
Nuvini Group to Acquire MK Solutions
-
Giftify, Inc.’s CardCash.com Achieves Record Performance with $150 Million in Gift Cards Delivered, 99.5% of Digital Orders Fulfilled in Under 2 Seconds
-
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services
-
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
-
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
